
|Articles|October 26, 2015
Twin Screw Wet Granulation for Solubility Enhancement of Poorly Water-Soluble Drugs
Author(s)BASF
Poorly-soluble APIs present formulation and development challenges. Excipient selection and manufacturing process development are crucial. Continuous twin-screw granulation is gaining acceptance as a manufacturing technology to address issues presented by these APIs and is offering high production capacity in a small footprint. In this dedicated dialogue, solubility enhancement expert Andreas Gryczke from BASF will answer additional questions that have been posed in our recent webinar on Twin Screw Wet Granulation for Solubility Enhancement of Poorly Water-Soluble Drugs.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
How GLP-1s, Digital Tech, and 505(b)(2) Strategies Are Reshaping the CDMO Landscape
3
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
4
Onshoring Requires a Plan for Training
5



